Effect of aripiprazole on prevention of delerium
Phase 2
- Conditions
- Delirium.Delirium, not induced by alcohol and other psychoactive substances
- Registration Number
- IRCT2017011810178N12
- Lead Sponsor
- Shahid Beheshti University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
18-80 yo patients admitted to intensive care unit
Exclusion criteria: pregnancy; breastfeeding; preexisting active delirium; bradycardia (heart rate <60); alcohol intoxication; liver failure (Child Pough Score: sever); kidney failure(GFR<15); history of anti-psychotic drug(s); ICU stay less than 3 days
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Delirium incidence. Timepoint: Entrance to study, Daily for 7 days. Method of measurement: Evaluation of CAM-ICU score.
- Secondary Outcome Measures
Name Time Method Drug effect on Lipid profile. Timepoint: Day 0 and 7. Method of measurement: Blood sample.;Drug effect on blood sugar. Timepoint: Daily. Method of measurement: Blood sample.;Drug effect on liver function tests. Timepoint: Day 0 and 7. Method of measurement: Blood sample.;Drug effect on ICU stay. Timepoint: Daily. Method of measurement: Counting the Admission days.